Slide 1: Managing Director's Report 12 Months to 31 July 2022
Managing Director’s Report 12 Months to 31 July 2022 14 September 2022
Slide 2: Vision, Values and Purpose Statement
Vision, Values and Purpose Statement Vision To optimise the health and development of adults, infants and children. Values Respect, Response, Responsibility Purpose In collaboration with key market participants, Clover develops customised high value nutritional ingredients that enhance the wellbeing
Slide 3: Full Year Performance Highlights
Full Year Performance Highlights ♣ Total full year Revenue ♣ New customers and $70.7m up 16.8% on products diversify revenue base FY21 $60.5m driven by increased demand ♣ Inventory at $36m increased $5.2m on FY21 full ♣ Net Profit after tax year $7.1m up 18.8% on ♣ Balance Sheet remains strong FY21
Slide 4: FY22 Update
FY22 Update ♣ Clover’s employees have worked through COVID conditions, managing to a COVID safe plan operating through the year without incident in operations ♣ Revenue in the first half year was stable at $29.7m with improved orders through the second half year at $40.9m ♣ Clover maintains a relati
Slide 5: Sales by Geography
Sales by Geography Europe ♣ Easing COVID19 conditions and increased customer engagement resulted in FY22 sales improving against FY21 Asia ANZ ♣ Asian sales showed some improvement with markets stabilizing as they come to terms with COVID-19 conditions ♣ AU / NZ improved as infant formula manufactur
Slide 6: Full Year 2022 Results
Full Year 2022 Results ♣ 16.8% year on year revenue increase. All regions showing AUD million 4E Reported 4E Reported 31 Jul 2022 31 Jul 2021 improvement Revenue $70.7 $60.5 ♣ Recovery from pantry stacking and COVID-19 restrictions in FY21 EBITDA $11.0 $9.5 lead to increased volumes and revenue NPBT
Slide 7: Balance Sheet 31 July 2022
Balance Sheet 31 July 2022 AUD Reported Reported 31 Jul 2022 31 Jul 2021 Movement $M $M $M ♣ Cash balance strong $10.1m Cash 10.1 9.1 1.0 Trade Receivables 19.6 13.3 6.3 ♣ Trade receivables up with strong finish to Inventories 36.0 30.8 5.2 FY22. Total Current Assets 66.9 54.7 12.2 Fixed Assets 23.7
Slide 8: Melody Dairies- New Zealand
Melody Dairies- New Zealand ♣ Clover has 42% ownership of a spray drying facility in Hamilton, New Zealand ♣ Following a delayed start up in FY21 due to COVID-19 the facility is now fully operational ♣ COVID-19 continued to impact utilisation of the dryer with Clover allowed entry into NZ only since
Slide 9: An Update on Growth Platforms
An Update on Growth Platforms Focus on Infant Formula New New Product Market Development Development 8
Slide 10: Market Development- Diversification
G r o wt h P l a t f o r ms Market Development- Diversification
Slide 11: Growth Platform: New products driving future growth
Growth Platform New products driving future growth ♣ Clover announced the successful clinical trial results improving the IQ for pre-term infants utilising a unique DHA emulsion product. The Medical Food product is branded Premneo with a commercialisation path in development ♣ Clover has developed a
Slide 12: Growth Platform: Infant formula provides new opportunities
Focus on Infant Growth Platform Formula Infant formula provides new opportunities ♣ China’s legislation requiring infant formula to contain a min 15mg/100Kcal of DHA and ARA has a commencement in Feb 2023, the license process has been hampered by COVID-19 delays ♣ Clover has worked with customers ac
Slide 13: Growth Platform: New market development
Growth Platform New market development ♣ Clover has achieved 125mg of DHA in a 3-gram gummy the highest in the world and is now supplying manufactures in the USA and Europe ♣ The company has added an employee and a new warehouse in Europe to better service opportunities ♣ The Company has grown its c
Slide 14: 1HFY23 Outlook & Priorities
1HFY23 Outlook & Priorities ♣ Managing the risk to employees, customers and suppliers continues to be the priority with COVID-19 still prevalent in our markets ♣ Supply chain challenges are a focus on obtaining raw materials and ensuring our customers are well serviced ♣ Re-engaging with customers a
Slide 15: Disclaimer
Disclaimer The release, publication or distribution of this presentation in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this presentation is released, published or distributed should inform themselves about and observe such restrictions. This